Position in ONC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$125,197,577
+$4,843,657 QoQ
Shares Held
439,336
+8.4% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#13
of 282 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 38%
Shared 0%
None 62%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. ONC ranks #18 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ONC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $125,197,577 | 439,336 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $120,353,920 | 405,273 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $115,092,946 | 378,832 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $117,628,717 | 345,256 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $67,656,867 | 279,493 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $79,687,834 | 292,787 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $37,972,679 | 205,580 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $47,554,581 | 211,815 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $40,996,078 | 287,349 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $55,221,618 | 353,102 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $31,814,057 | 176,392 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $32,397,820 | 180,118 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $51,873,885 | 290,936 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $66,978,315 | 310,761 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $69,062,696 | 314,007 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $40,649,036 | 301,506 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $56,370,896 | 348,291 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $78,168,286 | 414,466 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $63,396,533 | 233,996 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $105,258,021 | 289,967 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $93,941,395 | 273,730 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $89,113,697 | 256,015 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $53,458,560 | 206,891 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $50,760,314 | 177,211 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $27,465,892 | 145,785 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $23,507,604 | 190,948 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||